Market Size of Conjunctivitis Treatment Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 4.10 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Conjunctivitis Treatment Market Analysis
The conjunctivitis treatment market is expected to register a CAGR of 4.1% over the forecast period.
COVID-19 had a significant impact on the growth of the market during the pandemic period. This is due to the probable frequency of conjunctivitis conditions in coronavirus-infected patients. According to the NCBI article published in August 2021, conjunctivitis can manifest in COVID-19-infected people. Thus, increasing attention toward conjunctivitis during the pandemic had the potential to drive the demand for the market. However, the relaxation of strict lockdowns is expected to increase the patient inflow for conjunctivitis treatment procedures and contribute to the growth of the market studied over the next five years.
The market studied is expected to grow in the forecast period due to the high number of people suffering from conjunctivitis and the easier availability of treatment across the globe. According to the NCBI article published in April 2021, one of the most common ocular disorders among participants was allergic conjunctivitis, with 1.3%. As the disease is very common, hence, treatment is readily available.
Generally, conjunctivitis is self-diagnosable, and there is the least need to undergo any diagnostic test for this disease. Thus the incidence of allergic conjunctivitis is expected to contribute to the market's growth during the forecast period. As per another NIH article published in February 2021, viral and bacterial conjunctivitis are the two common forms of infectious conjunctivitis, with viral infection responsible for up to 80% of all acute conjunctivitis cases and bacterial infection accounting for between 50-75% of cases of infectious conjunctivitis in children. According to the same source, countries like China also have a high incidence of conjunctivitis. Moreover, as per the BMC article published in March 2022, the average annual hemorrhagic conjunctivitis incidence was 3.58/100,000 in mainland China. The rising incidence of hemorrhagic conjunctivitis is expected to drive the demand for conjunctivitis treatment, thereby contributing to market growth.
Hence, owing to the abovementioned factors, the market studied is expected to have steady growth over the forecast period.